Mohammad Akbar, MD
Otolaryngic Allergy · Pottsville, PANPI 1568430973
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,027 of the $1,636 with a category attached, or 62.8%. Aerin Medical Inc. accounts for 77.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $1,195 and has fallen 89.1% since, to $130 in 2025.
Across 31 payments — averaging $52.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$1K
- Optinose US, Inc.$264
- Regeneron Healthcare Solutions, Inc.$77
- Sanofi$24
What the payments were for
- Travel & lodging$60937%
- Food & beverage$1,02763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 15 | $1,271 |
| Optinose US, Inc. | 11 | $264 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Sanofi | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$810
How this compares
Too few otolaryngic allergy providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 71 | $3,710 |
| Ipratropium Bromide | 27 | $614 |
| Montelukast Sodium | 47 | $588 |
| Fluticasone Propionate | 43 | $509 |
| Ofloxacin | 24 | $488 |
| Levothyroxine Sodium | 21 | $232 |
| Levocetirizine Dihydrochloride | 22 | $203 |
| Famotidine | 11 | $176 |
| Cefdinir | 12 | $175 |
| Meclizine Hcl | 19 | $172 |
| Amoxicillin | 22 | $104 |
| Azithromycin | 21 | $101 |
| Prednisone | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Pottsville
- Elina ToskalaPhiladelphia$108K
- Zaher SrourHanover$4K
- Alexander KeszeliExton$3K
- Louis MariottiKingston$1K
- Sidney LipmanErie$958
- Jack AnonErie$642
- Allison HarbartJohnstown$280
- David RogersonJohnstown$80
- Kristin BrantJohnstown$15
- David ArmstrongJohnstown$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.